Simcere Pharma (02096): Zhou Yunshu appointed as the CEO.
Sunsine Pharmaceutical (02096) announced that Dr. Zhou Yunshu has been appointed as the Chief Executive Officer, effective from March 25, 2026. In this position, he will serve as a senior management member responsible for overseeing the overall management of the group's business operations. Dr. Zhou will report to the board of directors and must accept guidance and supervision from the board.
SIMCERE PHARMA (02096) announced that Dr. Zhou Yunshu has been appointed as Chief Executive Officer, effective from March 25, 2026. In this role, he will serve as a senior management personnel and be responsible for overseeing the overall management of the group's business operations. Dr. Zhou will report to the board of directors and receive guidance and supervision from them.
To focus on long-term strategic planning, major investment decisions, and overseeing the duties of the board of directors, Mr. Ren Jinsheng will no longer serve as Chief Executive Officer starting from March 25, 2026. Mr. Ren will continue to serve as the company's Chairman and Executive Director.
Related Articles
Under Musk's ownership, SpaceX is aiming to conduct the largest IPO in history, with plans to raise up to $75 billion.
US Stock Market Move | Popular Chinese concept stocks continue to rise, JD.com, Inc. Sponsored ADR Class A (JD.US) up more than 7%
KAISA HEALTH (00876) released its annual performance with a net loss attributable to shareholders of HK$46.678 million, a 0.7% increase year-on-year.
Under Musk's ownership, SpaceX is aiming to conduct the largest IPO in history, with plans to raise up to $75 billion.
US Stock Market Move | Popular Chinese concept stocks continue to rise, JD.com, Inc. Sponsored ADR Class A (JD.US) up more than 7%
KAISA HEALTH (00876) released its annual performance with a net loss attributable to shareholders of HK$46.678 million, a 0.7% increase year-on-year.
